|
2025-03-04 |
2025-03-03 |
S
Sale
|
Leonard Frank X
EVP, Pres., Novocure Oncology
Officer
|
2,527
-1.7%
18.54
USD 46,841
|
2,527
-1.7%
|
18.54
|
USD 46,841
|
|
|
2025-03-04 |
2025-03-03 |
S
Sale
|
Paravasthu Mukund
Chief Operating Officer
Officer
|
250
-0.8%
18.54
USD 4,634
|
250
-0.8%
|
18.54
|
USD 4,634
|
|
|
2025-03-04 |
2025-03-03 |
S
Sale
|
Weinberg Uri
Chief Innovation Officer
Officer
|
268
-0.2%
18.92
USD 5,071
|
268
-0.2%
|
18.92
|
USD 5,071
|
|
|
2025-03-04 |
2025-03-03 |
S
Sale
|
Cordova Ashley
Chief Executive Officer
Officer
|
2,053
-1.0%
18.54
USD 38,055
|
2,053
-1.0%
|
18.54
|
USD 38,055
|
|
|
2025-03-03 |
2025-02-28 |
S
Sale
|
Leonard Frank X
EVP, Pres., Novocure Oncology
Officer
|
2,770
-1.9%
18.28
USD 50,648
|
2,770
-1.9%
|
18.28
|
USD 50,648
|
|
|
2025-03-03 |
2025-02-28 |
S
Sale
|
Paravasthu Mukund
Chief Operating Officer
Officer
|
368
-1.2%
18.28
USD 6,729
|
368
-1.2%
|
18.28
|
USD 6,729
|
|
|
2025-03-03 |
2025-02-28 |
S
Sale
|
Weinberg Uri
Chief Innovation Officer
Officer
|
311
-0.2%
18.31
USD 5,695
|
311
-0.2%
|
18.31
|
USD 5,695
|
|
|
2025-03-03 |
2025-02-28 |
S
Sale
|
Weinberg Uri
Chief Innovation Officer
Officer
|
4,326
-2.5%
18.78
USD 81,254
|
4,326
-2.5%
|
18.78
|
USD 81,254
|
|
|
2025-03-03 |
2025-02-28 |
S
Sale
|
Cordova Ashley
Chief Executive Officer
Officer
|
2,341
-1.1%
18.28
USD 42,804
|
2,341
-1.1%
|
18.28
|
USD 42,804
|
|
|
2025-03-03 |
2025-02-27 |
S
Sale
|
Leupin Nicolas
Chief Medical Officer
Officer
|
161
-0.3%
20.55
USD 3,308
|
161
-0.3%
|
20.55
|
USD 3,308
|
|
|
2025-03-03 |
2025-02-27 |
S
Sale
|
Leupin Nicolas
Chief Medical Officer
Officer
|
830
-1.6%
19.92
USD 16,535
|
830
-1.6%
|
19.92
|
USD 16,535
|
|
|
2025-03-03 |
2025-02-27 |
S
Sale
|
Puri Michal Nath
Chief Human Resources Officer
Officer
|
225
-0.2%
20.55
USD 4,624
|
225
-0.2%
|
20.55
|
USD 4,624
|
|
|
2025-03-03 |
2025-02-27 |
S
Sale
|
Puri Michal Nath
Chief Human Resources Officer
Officer
|
1,162
-1.1%
19.92
USD 23,149
|
1,162
-1.1%
|
19.92
|
USD 23,149
|
|
|
2025-03-03 |
2025-02-27 |
S
Sale
|
Leonard Frank X
EVP, Pres., Novocure Oncology
Officer
|
1,989
-1.3%
20.55
USD 40,872
|
1,989
-1.3%
|
20.55
|
USD 40,872
|
|
|
2025-03-03 |
2025-02-27 |
S
Sale
|
Leonard Frank X
EVP, Pres., Novocure Oncology
Officer
|
10,277
-6.4%
19.92
USD 204,737
|
10,277
-6.4%
|
19.92
|
USD 204,737
|
|
|
2025-03-03 |
2025-02-27 |
S
Sale
|
Paravasthu Mukund
Chief Operating Officer
Officer
|
267
-0.9%
20.55
USD 5,487
|
267
-0.9%
|
20.55
|
USD 5,487
|
|
|
2025-03-03 |
2025-02-27 |
S
Sale
|
Paravasthu Mukund
Chief Operating Officer
Officer
|
1,379
-4.4%
19.92
USD 27,472
|
1,379
-4.4%
|
19.92
|
USD 27,472
|
|
|
2025-03-03 |
2025-02-27 |
S
Sale
|
Cordova Ashley
Chief Executive Officer
Officer
|
1,808
-0.9%
20.55
USD 37,153
|
1,808
-0.9%
|
20.55
|
USD 37,153
|
|
|
2025-03-03 |
2025-02-27 |
S
Sale
|
Cordova Ashley
Chief Executive Officer
Officer
|
9,345
-4.3%
19.92
USD 186,170
|
9,345
-4.3%
|
19.92
|
USD 186,170
|
|
|
2025-01-15 |
2025-01-11 |
S
Sale
|
Paravasthu Mukund
Chief Operating Officer
Officer
|
2,160
-6.4%
26.81
USD 57,906
|
2,160
-6.4%
|
26.81
|
USD 57,906
|
|
|
2024-11-06 |
2024-11-02 |
S
Sale
|
Paravasthu Mukund
Chief Operating Officer
Officer
|
44
-1.3%
16.69
USD 734
|
44
-1.3%
|
16.69
|
USD 734
|
|
|
2024-11-04 |
2024-11-01 |
S
Sale
|
Paravasthu Mukund
Chief Operating Officer
Officer
|
160
-4.4%
15.88
USD 2,540
|
160
-4.4%
|
15.88
|
USD 2,540
|
|
|
2024-11-04 |
2024-11-01 |
S
Sale
|
Leonard Frank X
EVP, Pres., Novocure Oncology
Officer
|
598
-0.4%
15.94
USD 9,531
|
598
-0.4%
|
15.94
|
USD 9,531
|
|
|
2024-11-04 |
2024-10-31 |
S
Sale
|
Puri Michal Nath
Chief Human Resources Officer
Officer
|
810
-0.7%
15.79
USD 12,792
|
810
-0.7%
|
15.79
|
USD 12,792
|
|
|
2024-08-05 |
2024-08-02 |
S
Sale
|
Cordova Ashley
Chief Financial Officer
Officer
|
688
-0.3%
20.14
USD 13,857
|
688
-0.3%
|
20.14
|
USD 13,857
|
|
|
2024-06-06 |
2024-06-04 |
S
Sale
|
Scannell Timothy J
Non-Executive Director
|
964
-24.5%
23.89
USD 23,027
|
964
-24.5%
|
23.89
|
USD 23,027
|
|
|
2024-06-06 |
2024-06-04 |
S
Sale
|
VERNON W ANTHONY
Non-Executive Director
|
964
-0.6%
23.89
USD 23,033
|
964
-0.6%
|
23.89
|
USD 23,033
|
|
|
2024-06-06 |
2024-06-04 |
S
Sale
|
LEUNG GABRIEL
Non-Executive Director
|
964
-1.2%
23.89
USD 23,025
|
964
-1.2%
|
23.89
|
USD 23,025
|
|
|
2024-03-05 |
2024-03-04 |
S
Sale
|
Leonard Frank X
EVP, Pres., Novocure Oncology
Officer
|
840
-0.5%
16.01
USD 13,448
|
840
-0.5%
|
16.01
|
USD 13,448
|
|
|
2024-03-05 |
2024-03-04 |
S
Sale
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Officer
|
1,217
-0.5%
16.01
USD 19,484
|
1,217
-0.5%
|
16.01
|
USD 19,484
|
|
|
2024-03-05 |
2024-03-01 |
S
Sale
|
Leonard Frank X
EVP, Pres., Novocure Oncology
Officer
|
1,679
-1.0%
16.03
USD 26,909
|
1,679
-1.0%
|
16.03
|
USD 26,909
|
|
|
2024-03-05 |
2024-03-01 |
S
Sale
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Officer
|
2,107
-0.8%
16.03
USD 33,769
|
2,107
-0.8%
|
16.03
|
USD 33,769
|
|
|
2024-02-29 |
2024-02-28 |
S
Sale
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Officer
|
2,303
-0.9%
16.14
USD 37,177
|
2,303
-0.9%
|
16.14
|
USD 37,177
|
|
|
2024-02-29 |
2024-02-28 |
S
Sale
|
Leonard Frank X
EVP, Pres., Novocure Oncology
Officer
|
2,078
-1.3%
16.14
USD 33,545
|
2,078
-1.3%
|
16.14
|
USD 33,545
|
|
|
2023-11-08 |
2023-11-07 |
PS
Planned sale
|
Shah Pritesh
Chief Growth Officer
Officer
|
382
-0.3%
12.65
USD 4,832
|
382
-0.3%
|
12.65
|
USD 4,832
|
|
|
2023-09-05 |
2023-09-01 |
S
Sale
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Officer
|
294
-0.1%
21.82
USD 6,414
|
294
-0.1%
|
21.82
|
USD 6,414
|
|
|
2023-09-05 |
2023-09-01 |
S
Sale
|
Shah Pritesh
Chief Growth Officer
Officer
|
273
-0.2%
21.82
USD 5,956
|
273
-0.2%
|
21.82
|
USD 5,956
|
|
|
2023-09-05 |
2023-09-01 |
S
Sale
|
Cordova Ashley
Chief Financial Officer
Officer
|
883
-0.9%
21.82
USD 19,265
|
883
-0.9%
|
21.82
|
USD 19,265
|
|
|
2023-08-04 |
2023-08-02 |
S
Sale
|
Cordova Ashley
Chief Financial Officer
Officer
|
1,144
-1.1%
30.25
USD 34,607
|
1,144
-1.1%
|
30.25
|
USD 34,607
|
|
|
2023-03-07 |
2023-03-07 |
PS
Planned sale
|
Leonard Frank X
President, CNS Cancers US
Officer
|
2,315
-4.1%
75.59
USD 174,999
|
2,315
-4.1%
|
75.59
|
USD 174,999
|
|
|
2023-03-07 |
2023-03-07 |
PS
Planned sale
|
Leonard Frank X
President, CNS Cancers US
Officer
|
6,003
-9.6%
75.00
USD 450,206
|
6,003
-9.6%
|
75.00
|
USD 450,206
|
|
|
2023-03-07 |
2023-03-03 |
S
Sale
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Officer
|
20,415
-8.9%
76.16
USD 1,554,794
|
20,415
-8.9%
|
76.16
|
USD 1,554,794
|
|
|
2023-03-07 |
2023-03-03 |
S
Sale
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Officer
|
1,692
-0.7%
76.16
USD 128,862
|
1,692
-0.7%
|
76.16
|
USD 128,862
|
|
|
2023-03-07 |
2023-03-03 |
S
Sale
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Officer
|
3,528
-1.5%
76.16
USD 268,690
|
3,528
-1.5%
|
76.16
|
USD 268,690
|
|
|
2023-03-07 |
2023-03-03 |
S
Sale
|
Shah Pritesh
Chief Growth Officer
Officer
|
16,909
-11.9%
76.16
USD 1,287,779
|
16,909
-11.9%
|
76.16
|
USD 1,287,779
|
|
|
2023-03-07 |
2023-03-03 |
S
Sale
|
Shah Pritesh
Chief Growth Officer
Officer
|
2,942
-2.0%
76.16
USD 224,061
|
2,942
-2.0%
|
76.16
|
USD 224,061
|
|
|
2023-03-07 |
2023-03-03 |
S
Sale
|
Shah Pritesh
Chief Growth Officer
Officer
|
1,570
-1.1%
76.16
USD 119,570
|
1,570
-1.1%
|
76.16
|
USD 119,570
|
|
|
2023-03-07 |
2023-03-03 |
S
Sale
|
Burke William Patrick
Chief Human Resources Officer
Officer
|
593
-0.9%
76.16
USD 45,163
|
593
-0.9%
|
76.16
|
USD 45,163
|
|
|
2023-03-07 |
2023-03-03 |
S
Sale
|
Cordova Ashley
Chief Financial Officer
Officer
|
775
-0.8%
76.16
USD 59,024
|
775
-0.8%
|
76.16
|
USD 59,024
|
|
|
2023-03-07 |
2023-03-03 |
S
Sale
|
Cordova Ashley
Chief Financial Officer
Officer
|
4,730
-4.4%
76.16
USD 360,234
|
4,730
-4.4%
|
76.16
|
USD 360,234
|
|
|
2023-03-07 |
2023-03-03 |
S
Sale
|
Leonard Frank X
President, CNS Cancers US
Officer
|
888
-1.4%
76.16
USD 67,630
|
888
-1.4%
|
76.16
|
USD 67,630
|
|
|
2023-03-07 |
2023-03-03 |
S
Sale
|
Leonard Frank X
President, CNS Cancers US
Officer
|
4,403
-6.5%
76.16
USD 335,330
|
4,403
-6.5%
|
76.16
|
USD 335,330
|
|
|
2023-03-06 |
2023-03-03 |
PS
Planned sale
|
Leonard Frank X
President, CNS Cancers US
Officer
|
2,059
-2.9%
77.64
USD 159,859
|
2,059
-2.9%
|
77.64
|
USD 159,859
|
|
|
2023-03-06 |
2023-03-02 |
S
Sale
|
Burke William Patrick
Chief Human Resources Officer
Officer
|
281
-0.4%
75.28
USD 21,153
|
281
-0.4%
|
75.28
|
USD 21,153
|
|
|
2023-03-06 |
2023-03-02 |
S
Sale
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Officer
|
1,213
-0.7%
75.28
USD 91,312
|
1,213
-0.7%
|
75.28
|
USD 91,312
|
|
|
2023-03-06 |
2023-03-02 |
S
Sale
|
Cordova Ashley
Chief Financial Officer
Officer
|
1,055
-1.1%
75.28
USD 79,418
|
1,055
-1.1%
|
75.28
|
USD 79,418
|
|
|
2023-03-06 |
2023-03-02 |
S
Sale
|
Shah Pritesh
Chief Growth Officer
Officer
|
937
-0.9%
75.28
USD 70,535
|
937
-0.9%
|
75.28
|
USD 70,535
|
|
|
2023-03-06 |
2023-03-02 |
S
Sale
|
Leonard Frank X
President, CNS Cancers US
Officer
|
844
-1.4%
75.28
USD 63,535
|
844
-1.4%
|
75.28
|
USD 63,535
|
|
|
2023-03-03 |
2023-03-02 |
PS
Planned sale
|
Leonard Frank X
President, CNS Cancers US
Officer
|
308
-0.5%
76.05
USD 23,424
|
308
-0.5%
|
76.05
|
USD 23,424
|
|
|
2023-03-03 |
2023-03-02 |
PS
Planned sale
|
Leonard Frank X
President, CNS Cancers US
Officer
|
3,799
-6.0%
75.32
USD 286,154
|
3,799
-6.0%
|
75.32
|
USD 286,154
|
|
|
2023-03-02 |
2023-03-01 |
S
Sale
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Officer
|
2,164
-1.2%
76.36
USD 165,248
|
2,164
-1.2%
|
76.36
|
USD 165,248
|
|
|
2023-03-02 |
2023-03-01 |
S
Sale
|
Leonard Frank X
President, CNS Cancers US
Officer
|
1,684
-2.6%
76.36
USD 128,594
|
1,684
-2.6%
|
76.36
|
USD 128,594
|
|
|
2023-03-02 |
2023-03-01 |
S
Sale
|
Shah Pritesh
Chief Growth Officer
Officer
|
1,923
-1.9%
76.36
USD 146,845
|
1,923
-1.9%
|
76.36
|
USD 146,845
|
|
|
2023-03-02 |
2023-03-01 |
S
Sale
|
Cordova Ashley
Chief Financial Officer
Officer
|
2,198
-2.2%
76.36
USD 167,845
|
2,198
-2.2%
|
76.36
|
USD 167,845
|
|
|
2023-03-02 |
2023-03-01 |
S
Sale
|
Burke William Patrick
Chief Human Resources Officer
Officer
|
755
-1.1%
76.36
USD 57,654
|
755
-1.1%
|
76.36
|
USD 57,654
|
|
|
2023-01-09 |
2023-01-05 |
S
Sale
|
Leonard Frank X
President, CNS Cancers US
Officer
|
7,183
-13.5%
120.00
USD 861,960
|
7,183
-13.5%
|
120.00
|
USD 861,960
|
|
|
2023-01-09 |
2023-01-05 |
PS
Planned sale
|
Leonard Frank X
President, CNS Cancers US
Officer
|
7,183
-13.5%
114.00
USD 818,863
|
7,183
-13.5%
|
114.00
|
USD 818,863
|
|
|
2023-01-09 |
2023-01-05 |
S
Sale
|
Leonard Frank X
President, CNS Cancers US
Officer
|
5,517
-10.7%
108.00
USD 595,836
|
5,517
-10.7%
|
108.00
|
USD 595,836
|
|
|
2023-01-09 |
2023-01-05 |
S
Sale
|
Leonard Frank X
President, CNS Cancers US
Officer
|
7,500
-14.0%
108.00
USD 810,000
|
7,500
-14.0%
|
108.00
|
USD 810,000
|
|
|
2023-01-09 |
2023-01-05 |
S
Sale
|
Leonard Frank X
President, CNS Cancers US
Officer
|
7,826
-14.5%
108.00
USD 845,208
|
7,826
-14.5%
|
108.00
|
USD 845,208
|
|
|
2023-01-09 |
2023-01-05 |
S
Sale
|
Leonard Frank X
President, CNS Cancers US
Officer
|
1,010
-2.1%
117.00
USD 118,170
|
1,010
-2.1%
|
117.00
|
USD 118,170
|
|
|
2023-01-09 |
2023-01-05 |
PS
Planned sale
|
Leonard Frank X
President, CNS Cancers US
Officer
|
526
-1.1%
115.03
USD 60,508
|
526
-1.1%
|
115.03
|
USD 60,508
|
|
|
2023-01-09 |
2023-01-05 |
S
Sale
|
Leonard Frank X
President, CNS Cancers US
Officer
|
417
-0.9%
108.00
USD 45,036
|
417
-0.9%
|
108.00
|
USD 45,036
|
|
|
2023-01-09 |
2023-01-05 |
PS
Planned sale
|
Leonard Frank X
President, CNS Cancers US
Officer
|
2,345
-4.6%
119.01
USD 279,073
|
2,345
-4.6%
|
119.01
|
USD 279,073
|
|
|
2023-01-09 |
2023-01-05 |
S
Sale
|
Weinberg Uri
Chief Science Officer
Officer
|
1,201
-2.7%
120.00
USD 144,120
|
1,201
-2.7%
|
120.00
|
USD 144,120
|
|
